Evaluation of Artificial Intelligence-Integrated Hearing Aids for Individuals with Hearing Loss
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Washington
About this trial
The goal of this clinical trial will be to evaluate the efficacy of artificial intelligence-integrated hearing aids in individuals with hearing loss. The main questions to answer are:
1. How effective is an artificial intelligence integrated hearing aid in improving speech perception in noise. 2. How does an artificial intelligence integrated hearing aid compare to currently available commercial hearing aids.
Eligibility criteria
Qualifiers
Minimum Age of 18 yo
Bilateral sensorineural hearing loss amenable to hearing aids
Able to give informed consent
Native English speaker
Disqualifiers
Unable to participate in informed consent
Use of a cochlear implant
Hearing loss not amenable to hearing aid use
Conductive hearing loss
Trial design
Treatments tested in this trial
- Artificial Intelligence Integrated Hearing Aid Use
- Phonak Infineo Hearing Aid
- Oticon Real Hearing Aid
Treatment groups
100 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov